Literature DB >> 25559624

Ibrutinib-associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma.

Michelle Furtado1, Michael L Wang2, Brian Munneke3, Jesse McGreivy3, Darrin M Beaupre3, Simon Rule4.   

Abstract

Entities:  

Keywords:  bone marrow; bruton tyrosine kinase inhibitor; ibrutinib; lymphocytosis; mantle cell lymphoma

Mesh：

Substances：

Year:  2015        PMID： 25559624     DOI： 10.1111/bjh.13275

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

Review 1.  Targeting B-cell receptor signaling in leukemia and lymphoma: how and why?

Authors:  John C Allen; Fatima Talab; Joseph R Slupsky
Journal:  Int J Hematol Oncol       Date:  2016-05-26

Review 2.  Rethinking clinical response and outcome assessment in a biologic age.

Authors:  Bruce D Cheson
Journal:  Curr Oncol Rep       Date:  2015-06       Impact factor: 5.075

Review 3.  Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma.

Authors:  Khalil Saleh; Morgane Cheminant; David Chiron; Barbara Burroni; Vincent Ribrag; Clémentine Sarkozy
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

Review 4.  Syk inhibitors in clinical development for hematological malignancies.

Authors:  Delong Liu; Aleksandra Mamorska-Dyga
Journal:  J Hematol Oncol       Date:  2017-07-28       Impact factor: 17.388

Review 5.  International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).

Authors:  A Younes; P Hilden; B Coiffier; A Hagenbeek; G Salles; W Wilson; J F Seymour; K Kelly; J Gribben; M Pfreunschuh; F Morschhauser; H Schoder; A D Zelenetz; J Rademaker; R Advani; N Valente; C Fortpied; T E Witzig; L H Sehn; A Engert; R I Fisher; P-L Zinzani; M Federico; M Hutchings; C Bollard; M Trneny; Y A Elsayed; K Tobinai; J S Abramson; N Fowler; A Goy; M Smith; S Ansell; J Kuruvilla; M Dreyling; C Thieblemont; R F Little; I Aurer; M H J Van Oers; K Takeshita; A Gopal; S Rule; S de Vos; I Kloos; M S Kaminski; M Meignan; L H Schwartz; J P Leonard; S J Schuster; V E Seshan
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

6.  Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.

Authors:  Shaojun Zhang; Vivian Changying Jiang; Guangchun Han; Dapeng Hao; Junwei Lian; Yang Liu; Rongjia Zhang; Joseph McIntosh; Ruiping Wang; Minghao Dang; Enyu Dai; Yuanxin Wang; David Santos; Maria Badillo; Angela Leeming; Zhihong Chen; Kimberly Hartig; John Bigcal; Jia Zhou; Rashmi Kanagal-Shamanna; Chi Young Ok; Hun Lee; Raphael E Steiner; Jianhua Zhang; Xingzhi Song; Ranjit Nair; Sairah Ahmed; Alma Rodriquez; Selvi Thirumurthi; Preetesh Jain; Nicolaus Wagner-Bartak; Holly Hill; Krystle Nomie; Christopher Flowers; Andrew Futreal; Linghua Wang; Michael Wang
Journal:  Nat Commun       Date:  2021-05-17       Impact factor: 17.694

7.  Severe Lymphocytosis in a Case of Diffuse Large B-Cell Lymphoma Treated by Ibrutinib

Authors:  Semra Paydaş; Ertuğrul Bayram; Mehmet Türker; Turan Özer
Journal:  Turk J Haematol       Date:  2021-08-12       Impact factor: 1.831
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.